RhumbLine Advisers’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9M | Buy |
652,558
+30,391
| +5% | +$553K | 0.01% | 983 |
|
|
2025
Q1 | $12.3M | Buy |
622,167
+1,088
| +0.2% | +$21.6K | 0.01% | 926 |
|
|
2024
Q4 | $10.7M | Buy |
621,079
+5,881
| +1% | +$101K | 0.01% | 1021 |
|
|
2024
Q3 | $12.3M | Buy |
615,198
+304,659
| +98% | +$6.09M | 0.01% | 964 |
|
|
2024
Q2 | $3.47M | Buy |
310,539
+15,844
| +5% | +$177K | ﹤0.01% | 1597 |
|
|
2024
Q1 | $1.94M | Buy |
294,695
+6,348
| +2% | +$41.9K | ﹤0.01% | 1921 |
|
|
2023
Q4 | $1.3M | Buy |
288,347
+617
| +0.2% | +$2.79K | ﹤0.01% | 2126 |
|
|
2023
Q3 | $1.03M | Buy |
287,730
+8,106
| +3% | +$29K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $1.03M | Sell |
279,624
-3,747
| -1% | -$13.8K | ﹤0.01% | 2267 |
|
|
2023
Q1 | $938K | Buy |
283,371
+33,776
| +14% | +$112K | ﹤0.01% | 2155 |
|
|
2022
Q4 | $968K | Buy |
249,595
+3,002
| +1% | +$11.6K | ﹤0.01% | 2146 |
|
|
2022
Q3 | $599K | Buy |
246,593
+15,479
| +7% | +$37.6K | ﹤0.01% | 2412 |
|
|
2022
Q2 | $458K | Buy |
+231,114
| New | +$458K | ﹤0.01% | 2537 |
|
|
2021
Q2 | – | Sell |
-64,698
| Closed | -$114K | – | 2983 |
|
|
2021
Q1 | $114K | Buy |
64,698
+100
| +0.2% | +$176 | ﹤0.01% | 2921 |
|
|
2020
Q4 | $126K | Buy |
64,598
+6,028
| +10% | +$11.8K | ﹤0.01% | 2938 |
|
|
2020
Q3 | $140K | Sell |
58,570
-10,804
| -16% | -$25.8K | ﹤0.01% | 2792 |
|
|
2020
Q2 | $203K | Buy |
69,374
+20,601
| +42% | +$60.3K | ﹤0.01% | 2765 |
|
|
2020
Q1 | $140K | Buy |
48,773
+2,409
| +5% | +$6.92K | ﹤0.01% | 2698 |
|
|
2019
Q4 | $185K | Buy |
46,364
+523
| +1% | +$2.09K | ﹤0.01% | 2772 |
|
|
2019
Q3 | $204K | Buy |
45,841
+16,443
| +56% | +$73.2K | ﹤0.01% | 2741 |
|
|
2019
Q2 | $114K | Buy |
29,398
+6,599
| +29% | +$25.6K | ﹤0.01% | 2907 |
|
|
2019
Q1 | $86K | Sell |
22,799
-480
| -2% | -$1.81K | ﹤0.01% | 2879 |
|
|
2018
Q4 | $56K | Buy |
23,279
+7,810
| +50% | +$18.8K | ﹤0.01% | 2935 |
|
|
2018
Q3 | $96K | Sell |
15,469
-591
| -4% | -$3.67K | ﹤0.01% | 2873 |
|
|
2018
Q2 | $72K | Buy |
+16,060
| New | +$72K | ﹤0.01% | 2893 |
|